HCV Eradication With DAAs Reduces Variceal Bleeding Risk HCV Eradication With DAAs Reduces Variceal Bleeding Risk
This study found that DAA-induced SVR in patients with hepatitis C is associated with a reduced risk of variceal bleeding, among both patients with and without established cirrhosis.Alimentary Pharmacology & Therapeutics
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news
More News: Bleeding | Cirrhosis | Drugs & Pharmacology | Gastroenterology | Health | Hepatitis | Hepatitis C | Study